Skip to main content
SpringerLink
Log in

Early Pregnancy Support: Evidence-Based Management

  • Chapter
  • First Online:
Clinical Management of Pregnancies following ART

  • 619 Accesses

Abstract

Early pregnancy is traditionally defined as the first trimester of pregnancy, which is up to 13 completed weeks of pregnancy. This is a time of rapid growth of the embryo to the stage of the fetus and completion of organogenesis. This is also considered the most anticipated and vulnerable stage of pregnancy, with 1 in 6 pregnancies ending in a miscarriage. This chapter outlines the evidence around the current pharmacological, supportive and life style advices that couples frequently ask about. Early pregnancy support helps the woman and the couple transition into the remainder of pregnancy with confidence and positive emotions. This plays a key role in the psychological and pregnancy outcomes. Pharmacological interventions help improve the pregnancy outcomes but only in limited number of associated disorders. The policy of “tender loving care” however has universal applications for all pregnant patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Musters AM, Taminiau-Bloem EF, van den Boogaard E, van der Veen F, Goddijn M. Supportive care for women with unexplained recurrent miscarriage: patient’s perspectives. Hum Reprod. 2011;26(4):873–7.

    Article  CAS  PubMed  Google Scholar 

  2. Li TC. Recurrent miscarriage: principles of management. Hum Reprod. 1998;13(2):478–82.

    Article  CAS  PubMed  Google Scholar 

  3. Van den Berg MM, Vissenberg R, Goddijn M. Recurrent miscarriage clinics. Obstet Gynecol Clin N Am. 2014;41:145–55.

    Article  Google Scholar 

  4. Nikcevic DAV, Tunkel SA, Nicolaides KH. psychological outcomes following missed abortions and provision of follow-up care. Ultrasound Obstet Gynecol. 1998;11(2):123–8.

    Article  CAS  PubMed  Google Scholar 

  5. Habayeb OM, Konje JC. The one-stop recurrent miscarriage clinic: an evaluation of its effectiveness and outcome. Hum Reprod. 2004;19(12):2952–8.

    Article  PubMed  Google Scholar 

  6. Stray-Pedersen B, Stray-Pedersen A. Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol. 1984;148.

    Google Scholar 

  7. Clifford K, Rai R, Regan L. Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum Reprod. 1997;12(2):387–9.

    Article  CAS  PubMed  Google Scholar 

  8. Coleman T, Chamberlain C, Davey M, Cooper SE, Leonardi-Bee J. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev. 2015;(12):CD010078.

    Google Scholar 

  9. Cooper S, Lewis S, Thornton JG, Marlow N, Watts K, Britton J, Grainge MJ, Taggar J, Essex H, Parrott S, Dickinson A, Whitemore R, Coleman T. The SNAP trial: a randomised placebo-controlled trial of nicotine replacement therapy in pregnancy—clinical effectiveness and safety until 2 years after delivery, with economic evaluation; Smoking, Nicotine and Pregnancy Trial Team. Health Technol Assess. 2014;18(54):1–128.

    Article  Google Scholar 

  10. Britton J, McNeill A, Hopkinson N. Nicotine without smoke: putting electronic cigarettes in context. BMJ. 2016;353:i1745.

    Article  PubMed  Google Scholar 

  11. Stade BC, Bailey C, Dzendoletas D, Sgro M, Dowswell T, Bennett D. Psychological and/or educational interventions for reducing alcohol consumption in pregnant women and women planning pregnancy. Cochrane Database Syst Rev. 2009;(2):CD004228.

    Google Scholar 

  12. Department of Health. Health risks from alcohol: new guidelines. 8 Jan 2016.

    Google Scholar 

  13. Kramer MS, McDonald SW. Aerobic exercise for women during pregnancy. Cochrane Database Syst Rev. 2006;(3):CD000180.

    Google Scholar 

  14. Lassi ZS, Salam RA, Haider BA, Bhutta ZA. Folic acid supplementation during pregnancy for maternal health and pregnancy outcomes. Cochrane Database Syst Rev. 2013;(3):CD006896.

    Google Scholar 

  15. De-Regil L, Peña-Rosas J, Fernández-Gaxiola AC, Rayco-Solon P. Effects and safety of periconceptional oral folate supplementation for preventing birth defects. Cochrane Database Syst Rev. 2015;(12):CD007950.

    Google Scholar 

  16. De-Regil L, Palacios C, Lombardo LK, Peña-Rosas J. Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev. 2016;(1):CD008873.

    Google Scholar 

  17. Martin TR, Bracken MB. The association between low birth weight and caffeine consumption during pregnancy. Am J Epidemiol. 1987;126(5):813–21.

    CAS  PubMed  Google Scholar 

  18. Jahanfar S, Jaafar S. Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcomes. Cochrane Database Syst Rev. 2015;(6):CD006965.

    Google Scholar 

  19. Wing Sze E, Hung Yu Ng E. Acupuncture in reproductive medicine. Womens Health. 2010;6(4):551–63.

    Google Scholar 

  20. Furber CM, McGowan L, Bower P, Kontopantelis E, Quenby S, Lavender T. Antenatal interventions for reducing weight in obese women for improving pregnancy outcome. Cochrane Database Syst Rev. 2013;(1):CD009334.

    Google Scholar 

  21. Chiswick C, Reynolds RM, Denison F, et al. Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial. Lancet Diabet Endocrinol. 2015;3(10):778–86.

    Article  CAS  Google Scholar 

  22. Syngelaki A, Nicolaides KH, Balani J, Hyer S, Akolekar R, Kotecha R, Pastides A, Shehata H. Metformin versus placebo in obese pregnant women without diabetes mellitus. N Engl J Med. 2016;374:434–43.

    Article  CAS  PubMed  Google Scholar 

  23. van der Linden M, Buckingham K, Farquhar C, Kremer JAM, Metwally M. Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev. 2015;(7):CD009154.

    Google Scholar 

  24. Coomarasamy A, Williams H, Truchanowicz E, Seed PT, Small R, Quenby S, Gupta P, Dawood F, Koot Y, Atik RB, Bloemenkamp KWM, Brady R, Briley AL, Cavallaro R, Cheong YC, Chu JJ, Eapen A, Ewies A, Hoek A, Kaaijk EM, Koks CAM, Li T-C, MacLean M, Mol BW, Moore J, Ross JA, Sharpe L, Stewart J, Vaithilingam N, Farquharson RG, Kilby MD, Khalaf Y, Goddijn M, Regan L, Rai R. A randomized trial of progesterone in women with recurrent miscarriages. N Engl J Med. 2015;373:2141–8.

    Article  CAS  PubMed  Google Scholar 

  25. Haas DM, Ramsey PS. Progestogen for preventing miscarriage. Cochrane Database Syst Rev. 2013;(10):CD003511.

    Google Scholar 

  26. Wahabi HA, Fayed AA, Esmaeil SA, Al Zeidan RA. Progestogen for treating threatened miscarriage. Cochrane Database Syst Rev. 2011;(12):CD005943.

    Google Scholar 

  27. The PRISM study is a large randomised, double-blind and placebo-controlled multi-centre trial of the effectiveness of progesterone in reducing miscarriage rates in women with early pregnancy bleeding. The PRISM trial is funded solely by NIHR-HTA (UK). http://www.birmingham.ac.uk/research/activity/mds/trials/bctu.

  28. de Jong PG, Kaandorp S, Di Nisio M, Goddijn M, Middeldorp S. Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia. Cochrane Database Syst Rev. 2014;(7):CD004734.

    Google Scholar 

  29. de Jong PG, Quenby S, Bloemenkamp KWM, Braams-Lisman BAM, de Bruin JP, Coomarasamy A, David M, DeSancho MT, van der Heijden OWH, Hoek A, Hutten BA, Jochmans K, Koks CAM, Kuchenbecker WH, Mol BWJ, Torrance HL, Scheepers HCJ, Stephenson MD, Verhoeve HR, Visser JV, de Vries JIP, Goddijn M, Middeldorp S. ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia – study protocol for a randomized controlled trial. Trials. 2015;16:208.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Akhtar MA, Sur S, Raine-Fenning N, Jayaprakasan K, Thornton JG, Quenby S. Heparin for assisted reproduction. Cochrane Database Syst Rev. 2013;(8):CD009452.

    Google Scholar 

  31. Check JH. The use of heparin for preventing miscarriage. Am J Reprod Immunol. 2012;67(4):326–33.

    Article  CAS  PubMed  Google Scholar 

  32. Hypertension in pregnancy: diagnosis and management NICE guidelines [CG107]. Published date: Aug 2010. Last updated: Jan 2011.

    Google Scholar 

  33. Kaandorp SP, Goddijn M, van der Post JA, Hutten BA, Verhoeve HR, Hamulyák K, Mol BW, Folkeringa N, Nahuis M, Papatsonis DN, Büller HR, van der Veen F, Middeldorp S. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med. 2010;362(17):1586–96.

    Article  CAS  PubMed  Google Scholar 

  34. Tang AW, Alfirevic Z, Turner MA, Drury JA, Small R, Quenby S. A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant. Hum Reprod. 2013;28(7):1743–52.

    Article  CAS  PubMed  Google Scholar 

  35. Wong LF, Porter T, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev. 2014;(10):CD000112.

    Google Scholar 

  36. Zeyneloglu HB, Onalan G. Remedies for recurrent implantation failure. Semin Reprod Med. 2014;32(4):297–305.

    Article  PubMed  Google Scholar 

  37. Quenby S, Farquharson RG. Human chorionic gonadotropin supplementation in recurring pregnancy loss: a controlled trial. Fertility Sterility. 1994;62(4):708–10.

    Article  CAS  PubMed  Google Scholar 

  38. Morley LC, Simpson N, Tang T. Human chorionic gonadotrophin (hCG) for preventing miscarriage. Cochrane Database Syst Rev. 2013;(1):CD008611.

    Google Scholar 

  39. Devaseelan P, Fogarty PP, Regan L. Human chorionic gonadotrophin for threatened miscarriage. Cochrane Database Syst Rev. 2010;(5):CD007422.

    Google Scholar 

  40. Rai L, Regan L. Recurrent miscarriage. Lancet. 2006;601–11.

    Google Scholar 

  41. American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012;98:1103–11.

    Article  Google Scholar 

  42. Kataoka K, Tomiya Y, Sakamoto A, Kamada Y, Hiramatsu Y, Nakatsuka M. Altered autonomic nervous system activity in women with unexplained recurrent pregnancy loss. J Obstet Gynaecol Res. 2015;41(6):912–8.

    Article  PubMed  Google Scholar 

  43. Kolte AM, Olsen LR, Mikkelsen EM, Christiansen OB, Nielsen HS. Depression and emotional stress is highly prevalent among women with recurrent pregnancy loss. Hum Reprod. 2015;4:777–82.

    Article  Google Scholar 

  44. Kolte AM, Olsen LR, Christiansen OB, Nielsen HS. Stress and depression at referral do not entail a lower chance of live birth/ongoing pregnancy for women with recurrent pregnancy loss. Copenhagen University Hospital Rigshospitalet, Recurrent Pregnancy Loss Unit Fertility Clinic Section 4071, Copenhagen, ESHRE 2015 abstract O-168.

    Google Scholar 

  45. Tang AW, Quenby S. Recent thoughts on management and prevention of recurrent early pregnancy loss. Curr Opin Obstet Gynecol. 2010;22(6):446–51.

    Article  PubMed  Google Scholar 

  46. Bailey S, Bailey C, Boivin J, Cheong Y, Reading I, Macklon N. A feasibility study for a randomised controlled trial of the positive reappraisal coping intervention, a novel supportive technique for recurrent miscarriage. BMJ Open. 2015;5, e007322.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynaecology, University Hospitals of Coventry and Warwickshire NHS Trust, Coventry, UK

    Valarmathy Kandavel MBBS, MRCOG, DGO

  2. Department of Reproductive Health, University of Warwick, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK

    Siobhan Quenby BSc, MD, FRCOG

Authors
  1. Valarmathy Kandavel MBBS, MRCOG, DGO
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Siobhan Quenby BSc, MD, FRCOG
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Valarmathy Kandavel MBBS, MRCOG, DGO .

Editor information

Editors and Affiliations

  1. Department of Maternity and Gynaecology, Royal Derby Hospital, University of Nottingham, Derby, United Kingdom

    Kanna Jayaprakasan

  2. Department of Obstetrics, Nottingham University Hospitals, Nottingham, United Kingdom

    Lucy Kean

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Kandavel, V., Quenby, S. (2017). Early Pregnancy Support: Evidence-Based Management. In: Jayaprakasan, K., Kean, L. (eds) Clinical Management of Pregnancies following ART. Springer, Cham. https://doi.org/10.1007/978-3-319-42858-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-42858-1_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-42856-7

  • Online ISBN: 978-3-319-42858-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation